 |
인쇄하기
취소
|
Samjin to export antiplatelet agent to overseas market
A Korean pharmaceutical company, Samjin Pharma, yesterday said it will export its antiplatelet agent containing clopidogrel hydrogen sulfate to China and the Philippines.
Under the agreement, Samjin will deliver US$50,000 worth of the drug in both of finished and active pharmaceutical forms.
Clopidogrel is marketed by Bristol-Myers Squibb and Sanofi-Aventis under the trade name of Plavix....
Under the agreement, Samjin will deliver US$50,000 worth of the drug in both of finished and active pharmaceutical forms.
Clopidogrel is marketed by Bristol-Myers Squibb and Sanofi-Aventis under the trade name of Plavix....
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.